WuXi AppTec Co. Ltd.

PNK: WUXAY · Real-Time Price · USD
8.45
0.71 (9.17%)
At close: May 02, 2025, 3:47 PM

Company Description

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally.

The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others.

It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.

The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services.

WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

WuXi AppTec Co. Ltd.
WuXi AppTec Co. Ltd. logo
Country CN
IPO Date Feb 24, 2021
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 39,414
CEO Dr. Ge Li Ph.D.

Contact Details

Address:
288 Fute Zhong Road
Shanghai,
CN
Website https://www.wuxiapptec.com

Stock Details

Ticker Symbol WUXAY
Exchange PNK
Fiscal Year January - December
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number US98260P1030
Employer ID -
SIC Code n/a

Key Executives

Name Position
Dr. Ge Li Ph.D. Co-Founder, Executive Chairman, President & Chief Executive Officer
Dr. Minzhang Chen Ph.D. Co-Chief Executive Officer & Executive Director
Dr. Qing Yang Ph.D. Co-Chief Executive Officer & Executive Director
Ming Shi Senior Vice President & Chief Financial Officer
Zhaohui Zhang Chief Operating Officer of China, Executive Vice President & Executive Director
Dr. Howard Wu J.D. Senior Vice President, General Counsel, Global Head of HR & Deputy Director of WuXi AppTec Management Institute
Dr. Jingchao Dong Ph.D. Senior Vice President & Head of RCS
Dr. Zhengguo Hu M.B.A. Global Chief Investment Officer & Vice Chairman
Ruijia Tang IR Director
Yuanzhou Zhang Joint Company Secretary

Latest SEC Filings

No SEC filings available.